A Study of Oral Ergocalciferol to Treat Pruritis in Hemodialysis Patients
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
Pruritis (itching) is common in many people with chronic renal failure on hemodialysis. There
may be many different reasons for the pruritis. Efforts to treat the problem have not been
very effective.
Vitamin D levels have been found to be low in many hemodialysis patients. Since vitamin D
plays an important role in the skin and is effective in treatment of certain skin conditions
that involve pruritis, it may have a role in treatment of pruritis in hemodialysis patients.
The objective of the investigators study is to determine the effect of supplementation with
oral vitamin D2 (ergocalciferol) on pruritis in hemodialysis patients.